InvestorsHub Logo
Followers 51
Posts 9097
Boards Moderated 1
Alias Born 10/25/2007

Re: spartex post# 12168

Thursday, 11/03/2022 10:19:29 AM

Thursday, November 03, 2022 10:19:29 AM

Post# of 13469
Primary efficacy analysis from Phase 2 study for personalized cancer vaccine program (mRNA-4157/V940) expected in 4Q22

Phase 3 RSV vaccine efficacy data could read out this winter

Phase 3 flu vaccine immunogenicity data expected in 1Q23


BIG NEWS IMMINENT$$$$$$$$$$
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News